Numerai GP LLC Reduces Holdings in CME Group Inc. (NASDAQ:CME)

Numerai GP LLC trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 49.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,173 shares of the financial services provider's stock after selling 5,149 shares during the period. Numerai GP LLC's holdings in CME Group were worth $1,201,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. SJS Investment Consulting Inc. increased its stake in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after purchasing an additional 97 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares during the last quarter. Financial Life Planners acquired a new stake in CME Group during the fourth quarter worth approximately $32,000. Knuff & Co LLC acquired a new stake in CME Group during the fourth quarter worth approximately $33,000. Finally, Banque Transatlantique SA acquired a new stake in CME Group during the fourth quarter worth approximately $35,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now owns 27,046 shares of the company's stock, valued at $6,774,211.62. The trade was a 12.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction on Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the sale, the insider now directly owns 8,336 shares in the company, valued at $2,339,164.96. This trade represents a 35.81% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 23,134 shares of company stock valued at $6,087,434. Company insiders own 0.30% of the company's stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Piper Sandler raised their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Oppenheimer raised their target price on shares of CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a research report on Friday, April 11th. Bank of America raised their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. UBS Group raised their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research report on Friday, April 25th. Finally, Barclays lifted their price target on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $256.80.

CME Group Trading Up 0.8%

Shares of CME stock traded up $2.29 during mid-day trading on Friday, reaching $276.29. The company's stock had a trading volume of 1,515,943 shares, compared to its average volume of 2,178,797. The company's 50 day simple moving average is $265.86 and its 200-day simple moving average is $247.04. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $99.56 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the firm posted $2.50 EPS. The business's revenue for the quarter was up 10.4% compared to the same quarter last year. On average, research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio is presently 50.30%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.